China Health Industries Holdings, Inc.
CHHE · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.62 | 0.01 | -0.16 | 0.88 |
| FCF Yield | -429.99% | 322.81% | 42.29% | 9.80% |
| EV / EBITDA | -12.92 | 45.75 | -7.98 | -1.01 |
| Quality | ||||
| ROIC | -4.16% | -3.35% | 2.25% | 7.38% |
| Gross Margin | 0.20% | -554.68% | 56.09% | 73.25% |
| Cash Conversion Ratio | 103.41 | -5.98 | 4.30 | 0.68 |
| Growth | ||||
| Revenue 3-Year CAGR | -74.19% | -97.00% | -11.21% | 14.86% |
| Free Cash Flow Growth | -2,098.01% | -61.83% | 146.67% | -54.71% |
| Safety | ||||
| Net Debt / EBITDA | -4.42 | 46.55 | -12.50 | -4.95 |
| Interest Coverage | -3,194.11 | -2,357.65 | 2,383.63 | 6,138.02 |
| Efficiency | ||||
| Inventory Turnover | 2.74 | 0.00 | 3.74 | 3.29 |
| Cash Conversion Cycle | -800.99 | 95,412.66 | 179.20 | 226.51 |